☆ 4.4 Article

High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Related references

Note: Only part of the references are listed.

Article Hematology

Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study

Raimondo De Cristofaro et al.

Summary: Patients with novel coronavirus pneumonia have increased thrombotic risk, with significantly higher levels of VWF, FVIII, and lower ADAMTS13 activity. This suggests virus-induced endothelial activation causing VWF/FVIII hypersecretion may be a potential therapeutic target in novel coronavirus pneumonia.

BLOOD COAGULATION & FIBRINOLYSIS (2021)

Add to Collection

Article Hematology

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

Ilaria Mancini et al.

Summary: Severe COVID-19 patients exhibit an increased risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased patients. The study found a significant alteration of the VWF-ADAMTS13 axis in COVID-19 patients, with an elevated VWF:Ag to ADAMTS13 activity ratio strongly associated with disease severity, enhancing the hypercoagulable state and risk of microthrombosis in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Letter Hematology

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19

Tiffany Pascreau et al.

THROMBOSIS RESEARCH (2021)

Add to Collection

Letter Peripheral Vascular Disease

Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance

Aurelien Philippe et al.

Summary: The study found significant differences in VWF collagen-binding ability and ADAMTS13 activity in COVID-19 patients, with VWF:CB levels serving as a valuable clinical biomarker for microthrombosis and COVID-19 severity.

ANGIOGENESIS (2021)

Add to Collection

Article Hematology

A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

Reyes Maria Martin-Rojas et al.

Summary: This study analyzed the coagulation parameters of critically and noncritically ill patients with COVID-19 bilateral pneumonia and found elevated levels of PAI-1 and vWF activity, as well as a mild reduction of ADAMTS13. These findings suggest that COVID-19 coagulopathy may be related to endothelial cell injury.

BLOOD COAGULATION & FIBRINOLYSIS (2021)

Add to Collection

Article Hematology

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients

Berangere S. Joly et al.

Summary: Clinical features, hemostatic laboratory parameters, VWF/ADAMTS13 axis, and ADAMTS13 conformation were investigated in critically ill COVID-19 patients at admission. The study found that an imbalance between high VWF antigen levels and normal or slightly decreased ADAMTS13 activity levels correlated with mortality, suggesting that these markers may reflect inflammation and endothelial damage rather than driving the thrombotic process of COVID-19.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Hematology

ADAMTS13 regulation of VWF multimer distribution in severe COVID-19

Soracha E. Ward et al.

Summary: Elevated plasma VWF and impaired ADAMTS-13 function in COVID-19 patients may contribute to microvascular thrombosis. Further research is needed to explore potential therapeutic interventions.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medical Laboratory Technology

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Cynthia Magro et al.

TRANSLATIONAL RESEARCH (2020)

Add to Collection

Article Hematology

Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

Janice Wang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

Corrado Lodigiani et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Review Hematology

Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus

Upendra K. Katneni et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Review Hematology

Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms

Shaun P. Jackson et al.

BLOOD (2019)

Add to Collection

Review Hematology

Inflammation, von Willebrand factor, and ADAMTS13

Junmei Chen et al.

BLOOD (2018)

Add to Collection

Article Hematology

von Willebrand factor and inflammation

C. Kawecki et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)

Add to Collection

Article Gastroenterology & Hepatology

Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases

Dorota Cibor et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Article Rheumatology

Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation

Johannes C. Nossent et al.

LUPUS SCIENCE & MEDICINE (2016)

Add to Collection

Article Hematology

A von Willebrand factor fragment containing the D′D3 domains is sufficient to stabilize coagulation factor VIII in mice

Andrew Yee et al.

BLOOD (2014)

Add to Collection

Review Hematology

von Willebrand factor, Jedi knight of the bloodstream

Timothy A. Springer

BLOOD (2014)

Add to Collection

Article Medical Laboratory Technology

Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease

Veronica H. Flood et al.

CLINICAL CHEMISTRY (2013)

Add to Collection

Article Hematology

Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease

V. H. Flood et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

Add to Collection

Article Hematology

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD

Veronica H. Flood et al.

BLOOD (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.